Clinical Trial Update: Schizophrenia Treatment Adherence Investigation (STAI)

View source ↗

Summary

This is a completed clinical trial update for the STAI schizophrenia treatment adherence study sponsored by Janssen-Cilag Pty Ltd, evaluating adherence in schiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Janssen-Cilag Pty Ltd | Conditions: Schizophrenia, Schizoaffective Disorder | Status: COMPLETED